OriCell Secures $110M Pre-IPO for Stem Cell Pipeline
April 13, 2026
Chinese clinical-stage biotech OriCell Therapeutics announced the cumulative closing of an over $110 million pre-IPO financing round to advance its stem cell therapies.
April 13, 2026
Chinese clinical-stage biotech OriCell Therapeutics announced the cumulative closing of an over $110 million pre-IPO financing round to advance its stem cell therapies.